目次

1. Access to high cost medicines and public health policies: A general overview 2. Health technology assessment, comparative effectiveness research 3. Evolution of UK policy to manage high drug costs 4. Managed entry agreement and high cost medicines (European perspective) 5. Setting a public health based medicines development agenda to support access to high cost medicines 6. Intellectual property issues, human right approaches and access to new essential medicines 7. Access to high cost medicines in Portugal 8. Access to high cost medicines in Africa with focus/case study of Uganda 9. Access to Biosimilars 10. Access to high cost medicines in Europe 11. Access to high cost medicines in Australia 12. Access to high-cost medicines in New Zealand 13. Access to high-cost medicines: a review of the literature (2011-2017)